Related Experiment Video
Updated: Jul 3, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Why consider neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder?
1Associate Professor, Department of Oncology, University of Alberta, and Medical Oncologist, Cross Cancer Institute, Edmonton, Alta.
Abstract
No abstract available in PubMed .
